Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 27 28 29 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Sopat–High-Tech Gründerfonds: investment, 201408 DIVESTMENT sale of shares in Sopat by HTGF to Dr Max Iann Invest GmbH 2014-08-06
Amptek–AMETEK: investment, 201408 acquisition of Amptek Inc 2014-08-05
Prosarix–Evolva: investment, 201408 acquisition in shares with 1.2m Evolva shares upfront + 2m shares milestones 2014-08-04
Santaris Pharma–Roche: investment, 201408 acquisition $250m upfront cash + $200m milestones 2014-08-04
i3 Membrane–DBU: grant, 201408 existent €250k to support developm of steel-based membrane technology 2014-08-01
i3 Membrane–Hamburg (govt): investment, 201408 investment by Innovationsstarter Fonds Hamburg + HTGF 2014-08-01
i3 Membrane–High-Tech Gründerfonds: investment, 201408 investment by HTGF + Innovationsstarter Fonds Hamburg 2014-08-01
Medineering–High-Tech Gründerfonds: investment, 201408 seed financing round from HTGF + Bayern Kapital + Born2Grow + consortium of business angels 2014-08-01
Medineering–SEVERAL: investment, 201408 seed financing round from HTGF + Bayern Kapital + Born2Grow + consortium of business angels 2014-08-01
IBL International–Tecan: investment, 201407 acquisition €29m in cash 2014-07-30
Riboxx–SEVERAL: investment, 201407–201501 crowdfunding €1m via Seedmatch 2014-07-30
Artes Biotechnology–Burnet Institute: malaria vaccine, 201407– collab development funded by PATH Malaria Vaccine Initiative (MVI) 2014-07-29
Artes Biotechnology–Burnet Institute: Metavax VLP technology, 201407 license existent Artes holds international patent rights 2014-07-29
BIA Separations–Showa Denko: investment, 201407 existent Showa Denko is co-owner of BIO Separations GmbH 2014-07-29
Showa Denko–BIA Separations: LC columns, 201407– collab expansion Showa Denko takes over BIA sales in Asia-Pacific region 2014-07-29
Boehringer–Hikma: investment, 201407– acquisition of US generic injectiables business Bedford Laboratories by Hikma from BI 2014-07-28
Boehringer–Zealand Pharma: peptide drug, 201407– collab + ww excl rights for cardio-metabolic disease €295m milestones + research funding + royalties 2014-07-28
Butalco–Lesaffre: investment, 201407 acquisition 2014-07-23
Boehringer–Univ Toronto: drug target discovery, 201407– collab to characterise new drug targets in ubiquitin system 2014-07-22
InflaRx–SEVERAL: investment, 201407 financing round Series B closing of 2nd + last tranche led by bm-t Thüringen 2014-07-17
LTS Lohmann Therapie-Systeme–Hopp Group: investment, 201407– acquisition all remaining shares by existent shareholder Dievini Hopp BioTech Holding 2014-07-17
Metrohm–Waters: chromatography s/w, 201407– collab product integration Empower CDS now can control Metrohm IC systems 2014-07-17
Paion–Pharmascience: investment, 201407 private placement €4m with 1.27m new shares €3.15/share to Pharmasience Intl Ltd 2014-07-17
Biosynthetic Technologies–Evonik: investment, 201407 financing round incl Evonik Venture Capital + BP Ventures 2014-07-16
Immatics–SEVERAL: investment, 201407 financing round Series D 2nd tranche €22m of €34m round Hopp + Strüngmann + Wellington Partners et al 2014-07-16
Siemens–Danaher: investment, 201407– acquisition Siemens Healthcare Diagnostics' Clinical Microbiology Business by Beckman Coulter 2014-07-16
Amcure–Germany (govt): grant, 201407 BMBF subsidy via Spinnovator programme managed by Ascenion 2014-07-15
Amcure–SEVERAL: investment, 201407 financing round Series A €5m led by LBBW Venture Capital GmbH 2014-07-15
Geisinger–Indivumed: tissue bank, 201407– collab to create cancer research biobanks at Geisinger + Indivumed 2014-07-15
Fosun–Miacom Diagnostics: molecular diagnostics, 201407– distribution molecular mulitplex sepsis + pneumonia assays by Fosun Diagnostics in CN + Asia 2014-07-14
Ayoxxa–SEVERAL: investment, 201407 financing round Series B €9m all existing investors + new investors 2014-07-10
International Council of Biotechnology Associations–BIO Deutschland: biotechnology, 201407 BIO Deutschland is founding member of ICBA 2014-07-10
International Council of Biotechnology Associations–EuropaBio: biotechnology, 201407 EuropaBio is founding member of ICBA 2014-07-10
International Council of Biotechnology Associations–Swiss Biotech Association: biotechnology, 201407 SBA is founding member of ICBA 2014-07-10
International Council of Biotechnology Associations–VCI: biotechnology, 201407 DIB is founding member of ICBA 2014-07-10
InSphero–Protea Biosciences: tissue analysis, 201407– collab product integration LAESI molecular MS imaging with 3D InSight microtissues 2014-07-09
Sophia Genetics–Endeavour Vision: investment, 201407 financing round Series B $13.75m led by Invoke Capital + Endeavour Vision + Swisscom 2014-07-08
Sophia Genetics–Invoke Capital: investment, 201407 financing round Series B $13.75m led by Invoke Capital + Endeavour Vision + Swisscom 2014-07-08
Sophia Genetics–SEVERAL: investment, 201407 financing round Series B $13.75m led by Invoke Capital + Endeavour Vision + Swisscom 2014-07-08
Analyticon Discovery–BRAIN: investment, 201407 acquisition of majority share €na by BRAIN w remaining shares held by management + key personnel 2014-07-03
Miacom Diagnostics–Fosun: investment, 201407 acquisition of 37% share by Shanghai Fosun Pharmaceutical Group 2014-07-02
Seragon Pharmaceuticals–Roche: investment, 201407– acquisition $725m upfront cash + $1b milestones by Genentech ANNOUNCED 2014-07-02
AbbVie–Apogenix: TRAIL receptor agonists, 201407 aquisition of ww rights to all TRAIL receptor agonists of Apogenix by AbbVie 2014-07-01
GeneWeave–SEVERAL: investment, 201407 financing round Series B $12m from Decheng Capital + Claremont Creek Ventures + XSeed Capital 2014-07-01
Qiagen–Altano Diagnostics: real-time PCR test, 201412– distribution ww of RealStar Ebolavirus RT-PCR Kit 1.0 by Qiagen 2014-07-01
Qiagen–Altano Diagnostics: real-time PCR test, 2014Q3– distribution of RealStar Filovirus RT-PCR Kit by Qiagen outside US 2014-07-01
Santhera–SEVERAL: investment, 201407–201408 sale CHF13.4m of 200k treasury common shares at CHF66.85/share 2014-07-01
RedHill Biopharma–Wilex: upamostat, 201406– license excl ww for Mesupron outside Greater China $1m upfront + royalties of up to 30% on net revenues 2014-06-30
Medigene–SEVERAL: investment, 201406–201407 capital increase €15.9m 3m new shares + 818.7k convertible bonds 2014-06-27
GW Pharmaceuticals–SEVERAL: investment, 201406 public offering $126.3m with 1.455m ADSs at $86.83/ADS at Nasdaq 2014-06-25
Merck (DE)–Mersana: ADC technology, 201406– collab €na using Flemixer technology to develop ADCs 2014-06-24
Agilent–Bruker Corp: chromatography data system, 201406 collab product integration exchange of instrument drivers for Compass CDS + OpenLab CDS 2014-06-23
Argenx–SEVERAL: investment, 201406–201408 IPO €41.8m 4.7m+0.2m shares at €8.5/shares at Euronext Brussels 2014-06-23
Bayer–Dimension Therapeutics: gene therapy, 201406– collab €20m upfront + $232m milestones + royalties developm of Hemophilia A gene therapy 2014-06-23
CytoTools–Instinctif Partners: public relations, 201406 service existent by Instinctif Partners 2014-06-23
CytoTools–SEVERAL: investment, 201406 capital increase €1.7m of CytoPharma GmbH incl €0.3m from >40% owner CytoTools 2014-06-23
Definiens–SEVERAL: investment, 201406 financing round €15m led by Wellington Partners + co-led by Gilde Healthcare 2014-06-23
Dimension Therapeutics–SEVERAL: investment, 201406 financing round $30m from OrbiMed + Fidelity Biosciences 2014-06-23
Paion–SEVERAL: investment, 201406–201407 capital increase €46.26m placement of 18.5m new shares €2.5/share 2014-06-18
Bruker Corp–Max Planck: mass spectrometry s/w, 201406 collab MaxQuant proteomics s/w supporting Bruker UHR-QTOF MS with MPI Matthias Mann group 2014-06-16
Florida State Univ–Bruker Corp: FTMS magnet, 201406 supply of 21 Tesla magnet for FTC-ICR MS co-designed by NHMFL 2014-06-16
Thermo Fisher–Excellims: ion mobility spectrometer, 201406 collab co-developm + product integration of MA3100 HPIMS with Orbitrap-based MS systems 2014-06-16
Univ Copenhagen–Thermo Fisher: mass spectrometer, 201406 supply existent Jesper Olsen at NNF CPR has been early-access user of Q Exactive HF system 2014-06-16
Covidien–Medtronic: investment, 201406– acquisition $42.9b in cash + shares ANNOUNCED 2014-06-15
Merck (DE)–MorphoSys: antibody cancer drug, 201406– strategic collab €na using Ylanthia to identify MAbs against immune checkpoints in cancer 2014-06-12
Genkyotex–Halsin Partners: public relations, 201406 service existent by Halsin Partners 2014-06-11
Idenix–Merck (US): investment, 201406– acquisition $3.85b cash tender offer $24.5/share ANNOUNCED 2014-06-09
4SC–Strüngmann Group: credit, 201406–201612 loan of up to €10m w 8% interest from Santo Holding (Deutschland) GmbH 2014-06-05
Genia–Roche: investment, 201406 acquisition $125m in cash + $225m milestones ANNOUNCED 2014-06-02
B Braun–CeGaT: personalised medicine, 201406 collab establishment of B Braun CeGaT LLC in Pennsylvania 2014-06-01
Saab–Bruker Corp: analytical instruments, 201406–201511 supply chemical detectors for Saab AWR system delivered to client in Kuwait 2014-06-01
Luphos–AMETEK: investment, 201405 acquisition of Luphos GmbH by AMETEK 2014-05-30
Bayer–Argenx: antibody technology, 201405– collab use of SIMPLE Antibody platform to discover + develop therap antibodies against Bayer targets 2014-05-28
Euprotec–Evotec: investment, 201405 acquisition 100% for £1.9m cash upfront + deferred business performace-based payment 2014-05-28
GSK–Genedata: Genedata Biologics, 201405– supply + collab GSK Biopharm RnD 2014-05-28
Roche–Stratos: DNA sequencing technology, 201405– collab r+d of SBX technology incl strategic investment by Roche 2014-05-26
Stratos–Roche: investment, 201405 strategic investment in Stratos Genomics in connection with collab on SBX technology 2014-05-26
Neuway Pharma–SEVERAL: investment, 201405 financing round Series A €2.7m led by Wellington Partners 2014-05-25
Neuway Pharma–Wellington Partners: investment, 201405 financing round Series A totalling €2.7m led by Wellington Partners 2014-05-25
Affimed–SEVERAL: investment, 201405–201409 IPO $56m+$8.4m offering 8m+1.2m common shares $7/share at Nasdaq 2014-05-23
Biobase–Qiagen: investment, 201405 acquisition €na by Qiagen 2014-05-20
Merck (DE)–Sysmex: molecular companion diagnostics, 201405– collab developm + commercialisation blood-based RAS biomarker mutation status test 2014-05-19
Bayer–Boston Scientific: investment, 201405–201409 acquisition $415m of interventional device business by Boston Scientific 2014-05-15
Co.don–SEVERAL: investment, 201405 capital increase €5m 2.6m new shares €1.9/share 2014-05-15
Thermo Fisher–Evans Analytical: ionisation technology, 201405– collab developm pulsed ion source technology for glow discharge MS 2014-05-14
Locate Therapeutics–Heraeus: investment, 201405 undisclosed investment €na by Heraeus 2014-05-09
Affymetrix–Danaher: lab automation, –201405 collab product integration fully automated ViewRNA eZ Assays on Leica BOND RX staining platform 2014-05-08
ImaginAb–SEVERAL: investment, 201405 financing round Series B $21m led by Mérieux Développement 2014-05-08
Lophius–SEVERAL: investment, 201405 financing round €2m VRD GmbH + S-Refit + another existing investor 2014-05-08
Eternygen–Evotec: drug discovery services, 201405– colllab identification + developm small-molecule inhibitors agianst target in metoblic disease 2014-05-06
Anokion–SEVERAL: investment, 201405 financing round Series A CHF33m ($37.5m) led by Novartis Venture + Novo Ventures + Versant Ventures 2014-05-05
Bayer–Cenix BioScience: drug target discovery, 201405– supply research service €na RNAi-based techn to identify targets for undisclosed indication 2014-05-05
Novartis–Ophthotech: pegpleranib, 201405– excl license + commercialisation agreem outside of US 2014-05-01
OptiBioCat project–EU (govt): grant, 201405– FP7 grant €7m to develop biocatalysts for cosmetics production 2014-05-01
Quantapore–SEVERAL: investment, 201405 financing round Series B up to $35m from undisclosed investors 2014-05-01
SomPharmaceuticals–SEVERAL: investment, 201404 private placement CHF750k Series A 2014-04-29
AllPure Technologies–Sartorius: investment, 201404– acquisition of majority stake €na by Sartorius Stedim Biotech signed 2014-04-28
CytoTools–SEVERAL: investment, 201404 capital increase €2.3m of DermaTools Biotech GmbH from mother CytoTools + existing investor 2014-04-28
Merck (US)–Agenus: antibody cancer drug, 201402– collab + license up to $100m milestones + royalties use of 4-Antibody Retrocyte Display technology 2014-04-28
Sequana Medical–SEVERAL: investment, 201404 financing round Series C CHF23m ($26.2m) led by LSP with NeoMed remaing largest investor 2014-04-28
next pagenext page 1 2 3 ... 27 28 29 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top